Imaging of perfusion using ultrasound
暂无分享,去创建一个
[1] H. Kauczor,et al. Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. , 2004, Ultrasound in medicine & biology.
[2] N. Rofsky,et al. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report. , 1998, Radiology.
[3] G. Corazza,et al. Doppler Sonography in the Diagnosis of Inflammatory Bowel Disease , 2004, Digestive Diseases.
[4] J. Blay,et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] G. Seidel,et al. Quantification of flow rates using harmonic grey-scale imaging and an ultrasound contrast agent: an in vitro and in vivo study. , 2001, Ultrasound in medicine & biology.
[6] Linda Chami,et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. , 2006, European journal of cancer.
[7] M. Reiser,et al. Contrast-enhanced ultrasound versus MS-CT in blunt abdominal trauma. , 2008, Clinical hemorheology and microcirculation.
[8] P. Terrier,et al. Dynamic contrast-enhanced Doppler ultrasound (DCE-US) is a useful radiological assessment to early predict the outcome of patients with gastrointestinal stromal tumors (GIST) treated with imatinib (IM). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] C. Bartolozzi,et al. Contrast‐Enhanced Doppler Ultrasound of Renal Artery Stenosis , 1999, Echocardiography.
[10] J. Soria,et al. Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma , 2007, Clinical Cancer Research.
[11] M. Blaivas,et al. Feasibility of FAST examination performance with ultrasound contrast. , 2005, The Journal of emergency medicine.
[12] Meng-Xing Tang,et al. Nonlinear propagation of ultrasound through microbubble contrast agents and implications for imaging , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[13] O. Bouché,et al. Recommandations pour la prise en charge des tumeurs stromales gastro-intestinales , 2005 .
[14] P. Phillips,et al. Contrast–agent detection and quantification , 2004, European radiology.
[15] Alberto Martegani,et al. Importance of staging of breast cancer and role of contrast ultrasound , 2001, European Radiology.
[16] David Cosgrove,et al. Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. , 2008, European urology.
[17] D. Cosgrove,et al. NUO 2703 Quantitation of enhanced transrectal ultraosound of the prostate using the echo-enhancing agent BR1 , 1997 .
[18] V. Lazar,et al. Sorafenib (S) and dacarbazine (D) combination in patients (pts) with advanced malignant solid tumors: Phase I study with tumor biopsy genomic analysis and dynamic contrast enhanced ultrasonography (DCE-US) , 2007 .
[19] David O. Cosgrove,et al. Renal Transplants: What Ultrasound Can and Cannot Do , 2008, Ultrasound quarterly.
[20] P. Terrier,et al. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] D. Cosgrove,et al. Can relative contrast agent concentration be measured in vivo with color Doppler US? , 1997, Radiology.
[22] J. Clorius,et al. Diuretic renography in hydronephrosis: renal tissue tracer transit predicts functional course and thereby need for surgery , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[23] F. Ridolfi,et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[24] Chris Harvey,et al. Clinical uses of microbubbles in diagnosis and treatment , 2009, Medical & Biological Engineering & Computing.
[25] T. Cooke,et al. Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival. , 1996, Annals of surgery.
[26] K. Jain. Gestational Trophoblastic Disease: Pictorial Review , 2005, Ultrasound quarterly.
[27] M. Gallegos,et al. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results. , 2005, Clinical hemorheology and microcirculation.
[28] M. Verani,et al. Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography: Comparison With Dobutamine Echocardiography and Thallium-201 Scintigraphy , 2003, Circulation.
[29] P. Grayburn,et al. Thinking outside the "box"-the ultrasound contrast controversy. , 2007, Journal of the American College of Cardiology.
[30] Baris Turkbey,et al. Imaging of tumor angiogenesis: functional or targeted? , 2009, AJR. American journal of roentgenology.
[31] I. Puls,et al. Cerebral arteriovenous transit time (CTT): a sonographic assessment of cerebral microcirculation using ultrasound contrast agents. , 1999, Ultrasound in medicine & biology.
[32] I. Kakadiaris,et al. A new method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast-enhanced intravascular ultrasound and differential image analysis. , 2008, International journal of cardiology.
[33] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[34] J. Soria,et al. Functional imaging using DCE-US: Which parameter for the early evaluation of antiangiogenetic therapies? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] S. Taylor-Robinson,et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. , 1998, Radiology.
[36] Michael Schirmer,et al. Value of Contrast-Enhanced Ultrasound in Rheumatoid Arthritis , 2022 .
[37] J. Cardoza,et al. Sonographic and Doppler Imaging in the Diagnosis and Treatment of Gestational Trophoblastic Disease , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[38] K. Zierler,et al. On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.
[39] U. Bogdahn,et al. Transcranial duplex ultrasound: experience with contrast enhancing agents. , 1997, International angiology : a journal of the International Union of Angiology.
[40] Christian Greis,et al. Technology overview: SonoVue (Bracco, Milan). , 2004, European radiology.
[41] Jagat Narula,et al. Imaging vulnerable plaque by ultrasound. , 2006, Journal of the American College of Cardiology.
[42] C. Serra,et al. Blunt abdominal trauma: emergency contrast-enhanced sonography for detection of solid organ injuries. , 2006, AJR. American journal of roentgenology.
[43] M. Hennerici,et al. Future developments in neurovascular ultrasound. , 2006, Frontiers of neurology and neuroscience.
[44] P. Sidhu,et al. CEUS in abdominal trauma: multi-center study , 2009, Abdominal Imaging.
[45] E. Leen,et al. A contrast-enhanced ultrasound study of benign and malignant breast tissue. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[46] S. Taylor-Robinson,et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study , 2003, Gut.
[47] F. Piscaglia,et al. Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[48] W. Voelker,et al. Effect of contrast application on interpretability and diagnostic value of dobutamine stress echocardiography in patients with intermediate coronary lesions: comparison with myocardial fractional flow reserve. , 2008, European heart journal.
[49] H. Pairleitner,et al. Three‐dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[50] R. Senior,et al. An update on contrast echocardiography. , 2009, Minerva cardioangiologica.
[51] D. Droste. Clinical Utility of Contrast-Enhanced Ultrasound in Neurosonology , 2008, European Neurology.
[52] B. Escudier,et al. Phase II trial of thalidomide in renal-cell carcinoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[53] A. Ignee,et al. Sonographic assessment of splanchnic arteries and the bowel wall. , 2008, European journal of radiology.
[54] N. Weissman,et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[55] Xiaoping Zhou,et al. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[56] D. Cosgrove,et al. Automated quantification of color Doppler signals: a preliminary study in breast tumors. , 1995, Radiology.
[57] F. Salaffi,et al. Colour Doppler ultrasonography evaluation of vascularization in the wrist and finger joints in rheumatoid arthritis patients and healthy subjects. , 2012, European journal of radiology.
[58] Chien-Cheng Chang,et al. Association between color doppler vascularity index, angiogenesis‐related molecules, and clinical outcomes in gastric cancer , 2009, Journal of surgical oncology.
[59] M. Krix. Quantification of enhancement in contrast ultrasound: a tool for monitoring of therapies in liver metastases , 2005, European radiology.
[60] Martin Wiesmann,et al. Perfusion harmonic imaging in acute middle cerebral artery infarction. , 2003, Ultrasound in medicine & biology.
[61] F. Hsieh,et al. Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. , 2000, Cancer research.
[62] Use of resistance index for the diagnosis of breast tumours. , 1996, Clinical radiology.
[63] E. Quaia,et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. , 2009, Gastroenterology.
[64] D. Cosgrove,et al. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[65] S. Koscielny,et al. Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography , 2010, Clinical Cancer Research.
[66] Linda Chami,et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. , 2006, AJR. American journal of roentgenology.
[67] J. L. Alcázar,et al. Transvaginal color Doppler for predicting pathological response to preoperative chemoradiation in locally advanced cervical carcinoma: a preliminary study. , 1999, Ultrasound in medicine & biology.
[68] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[69] Ji-fei Tang,et al. Contrast‐enhanced sonographic characteristics of neovascularization in carotid atherosclerotic plaques , 2008, Journal of clinical ultrasound : JCU.
[70] M. Torloni,et al. Evolution of 3-D power Doppler indices of fetal brain in normal pregnancy. , 2009, Ultrasound in medicine & biology.
[71] A R Jayaweera,et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.
[72] F. Han,et al. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound. , 2008, The British journal of radiology.
[73] C. Sofka. Molecular Imaging Using Contrast-Enhanced Ultrasound: Evaluation of Angiogenesis and Cell Therapy , 2010 .
[74] R. Berkowitz,et al. Gestational Trophoblastic Disease , 1998, Clinical obstetrics and gynecology.
[75] Yu-Ting Kuo,et al. Can Doppler sonography grade the severity of hepatitis C-related liver disease? , 2005, AJR. American journal of roentgenology.
[76] K. Wolf,et al. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. , 2009, Ultrasound in medicine & biology.
[77] S. Feinstein,et al. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. , 2004, American journal of physiology. Heart and circulatory physiology.